BCR, an ABL1 fusion partner in CML, is altered in lung adenocarcinoma and other cancers (75, https://www.aacr.org/professionals/research/aacr-project-genie/). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.